| Name | Title | Contact Details |
|---|
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.
At Hyperice, our mission is to provide everyone with the most innovative technology in accelerating recovery time, preventing injury, and enhancing the body`s ability to move more efficiently. All Hyperice products are developed and tested to meet the standards of the world`s best athletes.
The Access Group is a Berkeley Heights, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dermatology Specialists is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1987, Health Level Seven (HL7) is an ANSI-accredited non-profit that empowers global health data interoperability by developing standards and enabling their adoption and implementation – for a world where everyone can securely access and use the right health data when and where they need it.